BioCentury | Sep 16, 2002
Company News

Hybridon, Micrologix, OriGenix deal

...rights to HYBN’s ORI 1001, an HPV antisense compound. The compound previously was licensed to Origenix...
...of ORI 1001. Hybridon Inc. (HYBN), Cambridge, Mass. Micrologix Biotech Inc. (TSE:MBI; MGXIF), Vancouver, B.C. Origenix Technologies Inc....
BioCentury | Sep 12, 2002
Company News

Micrologix, Hybridon HPV deal

...rights to HYBN's ORI 1001, an HPV antisense compound. The compound previously was licensed to Origenix...
BioCentury | Sep 10, 2001
Clinical News

ORI-1001 topical gel: Began Phase I testing

...of E1 region of HPV Indication: Treat genital warts caused by HPV Endpoint: Safety Status: Origenix...
BioCentury | Mar 26, 2001
Company News

OriGenix board of directors update

Origenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Appointed: Michael Atkin, president and CEO of Aegera Therapeutics Inc. ; and Barry Markowsky, head of business development at GlaxoSmithKline (Canada) WIR Staff...
BioCentury | Mar 26, 2001
Company News

OriGenix management update

Origenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Hired: Anthony Payne as EVP of finance and business development, formerly an industry consultant WIR Staff Infectious...
BioCentury | Feb 1, 1999
Company News

OriGenix management update

...Financing, B15) OriGenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Hired: Douglas Jensen as president and CEO, formerly...
Items per page:
1 - 6 of 6
BioCentury | Sep 16, 2002
Company News

Hybridon, Micrologix, OriGenix deal

...rights to HYBN’s ORI 1001, an HPV antisense compound. The compound previously was licensed to Origenix...
...of ORI 1001. Hybridon Inc. (HYBN), Cambridge, Mass. Micrologix Biotech Inc. (TSE:MBI; MGXIF), Vancouver, B.C. Origenix Technologies Inc....
BioCentury | Sep 12, 2002
Company News

Micrologix, Hybridon HPV deal

...rights to HYBN's ORI 1001, an HPV antisense compound. The compound previously was licensed to Origenix...
BioCentury | Sep 10, 2001
Clinical News

ORI-1001 topical gel: Began Phase I testing

...of E1 region of HPV Indication: Treat genital warts caused by HPV Endpoint: Safety Status: Origenix...
BioCentury | Mar 26, 2001
Company News

OriGenix board of directors update

Origenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Appointed: Michael Atkin, president and CEO of Aegera Therapeutics Inc. ; and Barry Markowsky, head of business development at GlaxoSmithKline (Canada) WIR Staff...
BioCentury | Mar 26, 2001
Company News

OriGenix management update

Origenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Hired: Anthony Payne as EVP of finance and business development, formerly an industry consultant WIR Staff Infectious...
BioCentury | Feb 1, 1999
Company News

OriGenix management update

...Financing, B15) OriGenix Technologies Inc., Montreal, Quebec Business: Infectious diseases Hired: Douglas Jensen as president and CEO, formerly...
Items per page:
1 - 6 of 6